About Justin Culbertson
Justin has more than 10 years of experience serving publicly traded and privately held companies through technical accounting and financial reporting services. He focuses on clinical research organizations and similar service organizations in the constantly evolving life sciences industry. He has previously advised clients in the areas of new standard implementation, external audit, internal audit, risk management, mergers and acquisitions, process design and improvement, and internal and external financial reporting. He is also a member of RSM’s life sciences national industry leadership team.
In May 2021, Justin was selected as a senior analyst in RSM’s cutting edge industry eminence program, which positions its senior analysts to understand, forecast and communicate economic, business and technology trends shaping the industries RSM serves.
About Amanda Laskey
Amanda is a senior manager in the tax services practice in the New York City office of RSM US LLP, focusing on clients within the life sciences industry. In addition, she is a member of the firm’s Industry Eminence Program and works alongside RSM’s chief economist and other senior analysts to understand, forecast and communicate economic, business and technology trends affecting middle market businesses. She has nearly 10 years of experience assisting clients with claiming research and development tax credits at both the federal and state levels.
About Brian Winne
Brian Winne is a senior manager in RSM’s audit services focused on the life sciences industry. He was selected for the firm’s Industry Eminence Program in 2022 as a senior analyst covering the life sciences industry, working alongside the firm’s chief economist and other program participants to analyze trends and themes affecting life sciences companies in the middle market.
Brian has experience providing audit and business advisory services to his clients. He provides diverse accounting and compliance services to public and private clients in a variety of industries with a focus on biotech, life sciences and technology companies.